Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:
  • interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA);
  • clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development.
    • Learn   more about the EU Clinical Trials Register   including the source of the information and the legal basis.

    The EU Clinical Trials Register currently displays   36374   clinical trials with a EudraCT protocol, of which   5993   are clinical trials conducted with subjects less than 18 years old.
    The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
    Select Country:
    		 Select Age Range:
    Select Trial Status:
    		 Select Trial Phase:
    Select Gender:
    Select Date Range:
    to
    Select Rare Disease:
    IMP with orphan designation in the indication
    Orphan Designation Number:
    Results Status:
    Clear advanced search filters
     
    5,995 result(s) found. Displaying page 1 of 300.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-012817-23 Sponsor Protocol Number: MRU-09-02 Start Date*: 2009-09-08
    Sponsor Name:Maternite Regionale Universitaire de Nancy
    Full Title: Utilisation d’un surfactant exogène chez des nouveau-nés grands prématurés présentant une détresse respiratoire sévère en prévention de la dysplasie bronchopulmonaire
    Medical condition: Nouveau-né d’âge gestationnel inférieur à 33 semaines d’aménorrhée toujours sous ventilation assistée conventionnelle ou par oscillations à hautes fréquences (OHF), après 14+/-2 jours de vie, avec ...
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-007627-40 Sponsor Protocol Number: 199 Start Date*: 2010-01-21
    Sponsor Name:Medizinische Universität Wien
    Full Title: Evaluation of Local Anaesthetic Volumes for Caudal Blocks in Children
    Medical condition: Single shot caudal anaesthesia is the most common regional anaesthesia method in children. The recent study is designed to evaluate: 1. The cephalic spread of 0.7, 1.0 and 1.3 mL/kg local anaesth...
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-001916-41 Sponsor Protocol Number: C11-11 Start Date*: 2014-11-24
    Sponsor Name:Inserm
    Full Title: Fluconazole versus Micafungin in neonates with suspected or culture-proven Candidiasis: a randomized pharmacokinetic and safety study
    Medical condition: Neonates with suspected or culture-proven candidiasis
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed) IT (Prematurely Ended) NL (Completed) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004153-32 Sponsor Protocol Number: MK-7625A-034 Start Date*: 2017-07-25
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Sub...
    Medical condition: Treatment of complicated urinary tract infection (cUTI), including pyelonephritis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10037606 Pyelonephritis, unspecified LLT
    20.0 100000004862 10046576 Urinary tract infection, site not specified LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: HU (Ongoing) PL (Ongoing) GR (Ongoing) Outside EU/EEA
    Trial results: (No results available)
    EudraCT Number: 2013-004571-12 Sponsor Protocol Number: ANRS160RalFE Start Date*: 2014-02-06
    Sponsor Name:Inserm-ANRS
    Full Title: Evaluation of the pharmacokinetic properties and the tolerance of raltegravir during the third trimester of pregnancy
    Medical condition: HIV and pregnancy
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004865 10073025 Prevention of mother to child transmission of HIV infection LLT
    Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004706-90 Sponsor Protocol Number: STEM-AMI Start Date*: 2005-12-21
    Sponsor Name:AZIENDA OSPEDALIERA PROVINCIALE DI LECCO
    Full Title: A pilot study of G-CSF in patient with anterior acute MI undergoing primary coronary angioplasty
    Medical condition: AMI
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000891 Acute myocardial infarction LLT
    Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-010999-19 Sponsor Protocol Number: MEC-2009-074 Start Date*: 2010-07-07
    Sponsor Name:Erasmus MC - Sophia Children's Hospital
    Full Title: Protein and Energy Interactions in Critically Ill Children
    Medical condition: We want to study protein, glucose and lipid metabolism in critically ill septic children admitted to the PICU. As these children often receive insulin because of hyperglycemia due to insulin resist...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10022489 Insulin resistance LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-004105-10 Sponsor Protocol Number: RSV- NTR1023 Start Date*: 2008-07-07
    Sponsor Name:Wilhelmina Children's Hospital
    Full Title: Effect of palivizumab on respiratory syncytial virus-associated burden of disease – a randomized controlled trial
    Medical condition: Long term respiratory complaints as a possible consequence of RSV bronchiolitis
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-000069-41 Sponsor Protocol Number: THCHOG-2008-01 Start Date*: 2008-04-09
    Sponsor Name:Erasmus MC
    Full Title: Regulation of colloid osmotic pressure during cardiopulmonary bypass in infants: prospective randomised trial
    Medical condition: Regulation of COP during CPB in infants
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001674-32 Sponsor Protocol Number: NordiNet-IOS Start Date*: 2009-04-29
    Sponsor Name:Novo Nordisk Farma Oy
    Full Title: NordiNet International Outcome Study (NordiNet IOS)
    Medical condition: Small Gestation Age, Turner Syndrome, Growth Hormone Deficiency
    Disease: Version SOC Term Classification Code Term Level
    16.1 10014698 - Endocrine disorders 10056438 Growth hormone deficiency PT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2008-004633-24 Sponsor Protocol Number: PCT Start Date*: 2008-10-23
    Sponsor Name:Women's and Children's Hospital
    Full Title: A trial of position control therapy (PCT) for treatment of infantile gastro-oesophageal reflux
    Medical condition: gastro-oesophageal reflux related symptoms
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017884 Gastrooesophageal reflux LLT
    9.1 10017885 Gastrooesophageal reflux disease LLT
    9.1 10017924 Gastroesophageal reflux LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002847-28 Sponsor Protocol Number: CRLX030A2208 Start Date*: 2014-06-26
    Sponsor Name:Novartis Pharma Services AG
    Full Title: Multicenter, open-label, dose escalation study to evaluate safety, tolerability and pharmacokinetics of RLX030 in addition to standard of care in pediatric patients from birth to <18 years of age, ...
    Medical condition: acute heart failure
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004849 10000803 Acute heart failure LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-006109-85 Sponsor Protocol Number: RTBAIEOP012 Start Date*: 2012-02-14
    Sponsor Name:A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA
    Full Title: DIAGNOSTIC AND THERAPEUTIC STUDY FOR NEWLY DIAGNOSED RETINOBLASTOMA PATIENTS RTB AIEOP 012
    Medical condition: Newly diagnosed retinoblastoma patients
    Disease: Version SOC Term Classification Code Term Level
    14.1 10010331 - Congenital, familial and genetic disorders 10038916 Retinoblastoma PT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2015-000486-31 Sponsor Protocol Number: HD201 Start Date*: 2015-05-27
    Sponsor Name:Department of Anaesthesiology and Intensive Care, University of Tartu
    Full Title: The effect of milrinone on central and regional blood flow in preterm neonates undergoing patent ductus arteriosus ligation.
    Medical condition: Acute cardiorespiratory deterioration in preterm neonates 6-12 hours after open arterial duct ligation that is called post ligation cardiac syndrome (PLCS).
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: EE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004043-36 Sponsor Protocol Number: 004:TCELL Start Date*: 2017-04-28
    Sponsor Name:Uppsala University
    Full Title: CD19-TARGETING 3RD GENERATION CAR T CELLS FOR REFRACTORY B CELL MALIGNANCY – A PHASE II TRIAL
    Medical condition: CD19+ B cell lymphoma or leukemia
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-002278-33 Sponsor Protocol Number: PK_AB_NICU Start Date*: 2018-09-27
    Sponsor Name:Department of Clinical Pharmacology/Medical University of Vienna
    Full Title: Pharmacokinetics of antibiotics in cerebrospinal fluid of children with external ventricular drain
    Medical condition: We will obtain pharmacokinetic data of cefuroxime, vancomycin, gentamicin, ampicillin, linezolid and piperacillin/tazobactam in cerebrospinal fluid and plasma of children with external ventricular ...
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-002114-80 Sponsor Protocol Number: TIP-15-01 Start Date*: 2017-03-14
    Sponsor Name:AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI
    Full Title: Efficacy and safety of dexmedetomidine during weaning from analgesia and sedation in Pediatric Intensive Care Unit. A multicenter, double-blind, randomized controlled trial.
    Medical condition: analgesia and sedation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10039897 Sedation PT
    20.0 100000004865 10002182 Analgesia LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002098-30 Sponsor Protocol Number: Start Date*: 2006-09-04
    Sponsor Name:Erasmus Medical Centre Rotterdam
    Full Title: Efficacy of Inhaled RhDNase in Mechanically Ventilated Pediatric Patients with an Atelectasis
    Medical condition: Study population are: Children who develop an atelectasis during mechanical ventilation. An atelectasis is a collapsed part of the lung that is often caused by mucus plugs.
    Disease:
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-003067-46 Sponsor Protocol Number: FZ07/04 Start Date*: 2007-10-03
    Sponsor Name:Flevoziekenhuis
    Full Title: Effect of domperidone and omeprazole in gastro-oesophageal reflux disease in infants between 0 and 2 years.
    Medical condition: Gastro-oesophageal reflux disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017924 Gastroesophageal reflux LLT
    Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001923-20 Sponsor Protocol Number: PALIFERMIN EXPANDED ACCESS PROTOCO Start Date*: 2006-04-27
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: Palifermin use in patients , out of clinical investigation, which are receiving chemioterapic therapy with staminal cells to reduce severuty and incidence of mucositis.
    Medical condition: mucositis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028128 Mucositis management LLT
    Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    EU Clinical Trials Register Service Desk: https://servicedesk.ema.europa.eu
    European Medicines Agency © 1995-2020 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands     Legal notice
    EMA HMA